RZLT
Rezolute Inc

850
Loading...
Loading...
Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its clinical assets include Ersodetug, a potential treatment for hypoglycemia caused by multiple forms of hyperinsulinism, and RZ402, an oral plasma kallikrein inhibitor and potential therapy for the chronic treatment of diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
59

Frequently Asked Questions

What is Market Cap of Rezolute Inc?
What is the 52-week high for Rezolute Inc?
What is the 52-week low for Rezolute Inc?
What is Rezolute Inc stock price today?
What was Rezolute Inc stock price yesterday?
What is the PE ratio of Rezolute Inc?
What is the Price-to-Book ratio of Rezolute Inc?
What is the 50-day moving average of Rezolute Inc?
How many employess does Rezolute Inc has?

Latest RZLT News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.